贝尔法斯特皇后大学和伦敦大学学院的研究人员发现一种最初开发治疗心血管疾病的药物有可能降低糖尿病引起的并发症-失明。根据世卫组织最近估计,全球约有4.22亿人患有糖尿病。这种疾病最常见的并发症之一就是视力丧失。糖尿病黄斑水肿发生在大约7%的糖尿病患者中,失明在西方世界是最常见的原因之一。在英国,糖尿病视网膜病变这个影响视觉的并发症与健康息息相关,相关的社会保健费用花 Researchers at Queens University Belfast and University College London have found that a drug that was originally developed to treat cardiovascular disease has the potential to reduce diabetes complications - blindness. According to WHO’s recent estimates, some 422 million people worldwide have diabetes. One of the most common complications of this disease is loss of vision. Diabetic macular edema occurs in about 7% of diabetics, and blindness is one of the most common causes in the Western world. In the UK, diabetic retinopathy, which affects visual complications and health, is associated with the cost of social care spending